Dr. Kenneth Liechty is a Pediatric and Fetal Surgeon. His research has been focused primarily in the field of wound healing and regenerative medicine, with an emphasis on elucidating the mechanisms involved in the regenerative response to injury in the fetus, the role of stem cells in tissue repair, and the correction of abnormal healing in the adult. His team has contributed significantly to the understanding of regenerative healing in the skin and tendon, as well as the correction of impaired healing in diabetics. Dr. Liechty’s research team has pioneered the role of dysregulation of microRNAs in the diabetic wound healing impairment and the mechanisms of stem cell and gene therapy in the correction of this impairment. He and his team are developing novel treatment paradigms using stem cells and gene therapy strategies to promote healing and tissue regeneration in multiple tissues by modulating the inflammatory response, angiogenesis, the composition of the extracellular matrix, and the progenitor cell content. The goal of this regenerative medicine approach is to restore normal tissue architecture and function and to prevent the complications of impaired healing or scar formation following injury.